1. Home
  2. DAWN vs PGC Comparison

DAWN vs PGC Comparison

Compare DAWN & PGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAWN
  • PGC
  • Stock Information
  • Founded
  • DAWN 2018
  • PGC 1921
  • Country
  • DAWN United States
  • PGC United States
  • Employees
  • DAWN N/A
  • PGC N/A
  • Industry
  • DAWN Biotechnology: Pharmaceutical Preparations
  • PGC Commercial Banks
  • Sector
  • DAWN Health Care
  • PGC Finance
  • Exchange
  • DAWN Nasdaq
  • PGC Nasdaq
  • Market Cap
  • DAWN 624.8M
  • PGC 536.5M
  • IPO Year
  • DAWN 2021
  • PGC N/A
  • Fundamental
  • Price
  • DAWN $7.20
  • PGC $28.46
  • Analyst Decision
  • DAWN Strong Buy
  • PGC Strong Buy
  • Analyst Count
  • DAWN 7
  • PGC 2
  • Target Price
  • DAWN $27.86
  • PGC $37.00
  • AVG Volume (30 Days)
  • DAWN 2.1M
  • PGC 98.6K
  • Earning Date
  • DAWN 08-05-2025
  • PGC 07-21-2025
  • Dividend Yield
  • DAWN N/A
  • PGC 0.74%
  • EPS Growth
  • DAWN N/A
  • PGC N/A
  • EPS
  • DAWN N/A
  • PGC 1.81
  • Revenue
  • DAWN $187,638,000.00
  • PGC $238,300,000.00
  • Revenue This Year
  • DAWN $16.42
  • PGC $28.96
  • Revenue Next Year
  • DAWN $47.52
  • PGC $17.65
  • P/E Ratio
  • DAWN N/A
  • PGC $14.94
  • Revenue Growth
  • DAWN 2190.50
  • PGC 16.62
  • 52 Week Low
  • DAWN $5.64
  • PGC $23.96
  • 52 Week High
  • DAWN $16.76
  • PGC $37.88
  • Technical
  • Relative Strength Index (RSI)
  • DAWN 62.39
  • PGC 63.17
  • Support Level
  • DAWN $6.71
  • PGC $26.32
  • Resistance Level
  • DAWN $7.12
  • PGC $27.23
  • Average True Range (ATR)
  • DAWN 0.32
  • PGC 0.70
  • MACD
  • DAWN 0.10
  • PGC 0.35
  • Stochastic Oscillator
  • DAWN 85.05
  • PGC 94.61

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

About PGC Peapack-Gladstone Financial Corporation

Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.

Share on Social Networks: